The Effect of Pomegranate Juice and Sumac Consumption in the Treatment of Outpatients with COVID-19.

Fatemeh ForouzanfarMohammadreza AhmadpoorMostafa Moshirian FarahiAli HadianfarAmirhossein SahebkarHabibollah EsmailyMohsen NematyHassan Rakhshandeh

Published in: Mediators of inflammation (2022)

Clinical trials of outpatients have limitations such as patients' resilience to post-COVID-19 follow-up. However, the use of pomegranate juice and sumac can be efficacious in reducing COVID-19 symptoms. This trial is registered with IRCT20190406043175N3.

Keyphrases

coronavirus disease
sars cov
clinical trial
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
respiratory syndrome coronavirus
phase ii
phase iii
prognostic factors
study protocol
climate change
social support
depressive symptoms
patient reported
replacement therapy
placebo controlled